Hank McKinnell, Pfizer’s former chief executive, is expected to receive pension benefits worth US$82.3 million.
He will also get $77.9 million in deferred compensation as well as cash and stock exceeding $20.7 million.
McKinnell could also receive an additional $18.3 million stock award, which is contingent on Pfizer’s future share performance.
The total amount he could get is nearly $200 million.
McKinnell stepped down in July under pressure from investors upset about his retirement package and a decline in Pfizer’s stock of nearly 40% during his five-year tenure.
His replacement, Jeffrey Kindler, has a much lower salary, no contract and more pay tied to the performance of the company’s shares.
To comment on this story email craig.sebastiano@rci.rogers.com.